^
No biomarker
Pancreatic Adenocarcinoma
gemcitabine + albumin-bound paclitaxel
Sensitive
:
A1
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil + leucovorin calcium + nanoliposomal irinotecan
Sensitive
:
A1
No biomarker
Pancreatic Adenocarcinoma
LV5FU2
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
CAPOX
Sensitive
:
A2
NTRK3 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Pancreatic Adenocarcinoma
entrectinib
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
erlotinib
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
capecitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil + capecitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
gemcitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
gemcitabine + capecitabine
Sensitive
:
A2
BRCA1 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
A2
BRCA2 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
A2
PALB2 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil + irinotecan
Sensitive
:
A2
NTRK1 fusion
Pancreatic Adenocarcinoma
entrectinib
Sensitive
:
A2
MSI-H/dMMR
Pancreatic Adenocarcinoma
pembrolizumab
Sensitive
:
A2
NTRK2 fusion
Pancreatic Adenocarcinoma
entrectinib
Sensitive
:
A2
NTRK1 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive
:
C1
RET fusion
Pancreatic Adenocarcinoma
pralsetinib
Sensitive
:
C1
TMB-H
Pancreatic Adenocarcinoma
pembrolizumab
Sensitive
:
C1
KRAS G12R
Pancreatic Adenocarcinoma
selumetinib
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our